Nasmed Ozel Saglik Stock Current Valuation
EGEPO Stock | 26.30 0.82 3.02% |
Valuation analysis of Nasmed Ozel Saglik helps investors to measure Nasmed Ozel's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Nasmed Ozel's price fluctuation is not too volatile at this time. Calculation of the real value of Nasmed Ozel Saglik is based on 3 months time horizon. Increasing Nasmed Ozel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nasmed Ozel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nasmed Stock. However, Nasmed Ozel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 26.3 | Real 20.28 | Hype 26.3 | Naive 27.42 |
The intrinsic value of Nasmed Ozel's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nasmed Ozel's stock price.
Estimating the potential upside or downside of Nasmed Ozel Saglik helps investors to forecast how Nasmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nasmed Ozel more accurately as focusing exclusively on Nasmed Ozel's fundamentals will not take into account other important factors: Nasmed Ozel Saglik Company Current Valuation Analysis
Nasmed Ozel's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Nasmed Ozel Saglik has a Current Valuation of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Valuation (which currently averages 0.0) industry. This indicator is about the same for all Turkey stocks average (which is currently at 0.0).
Nasmed Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nasmed Ozel's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nasmed Ozel could also be used in its relative valuation, which is a method of valuing Nasmed Ozel by comparing valuation metrics of similar companies.Nasmed Ozel is currently under evaluation in current valuation category among its peers.
Nasmed Fundamentals
Return On Equity | 0.0238 | |||
Return On Asset | 0.0221 | |||
Profit Margin | 0.03 % | |||
Operating Margin | 0.06 % | |||
Shares Owned By Insiders | 8.00 % | |||
Revenue | 229.67 M | |||
Gross Profit | 40.73 M | |||
EBITDA | 31.65 M | |||
Book Value Per Share | 2.45 X | |||
Earnings Per Share | 0.14 X | |||
Number Of Employees | 851 |
About Nasmed Ozel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nasmed Ozel Saglik's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nasmed Ozel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nasmed Ozel Saglik based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nasmed Stock
Nasmed Ozel financial ratios help investors to determine whether Nasmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nasmed with respect to the benefits of owning Nasmed Ozel security.